机构:[1]Department of Ophthalmology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.[2]Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Ophthalmology Center, Beijing, People's Republic of China.研究所眼科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[3]High Altitude Ocular Disease Research Center of People's Hospital of Shigatse City and Tongren Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shigatse, People's Republic of China.[4]Department of Ophthalmology, Shigatse People's Hospital, Shigatse, Xizang, People's Republic of China.
the Changning District Health and Family Planning Commission Fund (No. 2022QN04),
Shanghai Municipal Health Commission Clinical Research Program (No. 20244Y0213), the Research Fund of Shanghai
Tongren Hospital, Shanghai Jiaotong University School Medicine (No. TRYJ2024LC07), the Norman Bethune Public
Welfare Foundation’s “Bright Vision, Bathing in Light” Project (No. BCF-KH-YK-20240906-12), Scientific Research
Fund of Compound Chinese Medicine for the Treatment of diabetes Microangiopathy (No. Z-2017-26-2302), Major
Science and Technology Project of Yunnan Provincial Science and Technology Department — Biomedical Specialization
(No. 202402AA310074), National Natural Science Foundation of China (82371072), the Shanghai Jiao Tong University
“Jiao Tong Star” Program – Medical-Engineering Cross Research Fund (No. 2023DHYGJC-YBA06 and YG2024LC13),
and High Altitude Ocular Disease Research Center of People’s Hospital of Shigatse City and Tongren Hospital Affiliated
to Shanghai Jiao Tong University School of Medicine, P. R. China.
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类|4 区医学
小类|3 区眼科学
最新[2025]版:
大类|4 区医学
小类|3 区眼科学
第一作者:
第一作者机构:[1]Department of Ophthalmology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
通讯作者:
通讯机构:[1]Department of Ophthalmology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.[3]High Altitude Ocular Disease Research Center of People's Hospital of Shigatse City and Tongren Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shigatse, People's Republic of China.[4]Department of Ophthalmology, Shigatse People's Hospital, Shigatse, Xizang, People's Republic of China.
推荐引用方式(GB/T 7714):
Wei Qingquan,Wang Wenying,Qiu Qinghua.Central Macular Thickness and Foveal Avascular Zone are Indicators of Early Diabetic Retinopathy[J].Clinical Ophthalmology (Auckland, N.Z.).2025,19:3505-3514.doi:10.2147/OPTH.S544037.
APA:
Wei Qingquan,Wang Wenying&Qiu Qinghua.(2025).Central Macular Thickness and Foveal Avascular Zone are Indicators of Early Diabetic Retinopathy.Clinical Ophthalmology (Auckland, N.Z.),19,
MLA:
Wei Qingquan,et al."Central Macular Thickness and Foveal Avascular Zone are Indicators of Early Diabetic Retinopathy".Clinical Ophthalmology (Auckland, N.Z.) 19.(2025):3505-3514